Phase III clinical trial - Sarcomes

STRASS 2 - ETUDE 1809-STBSG
Sarcomes
Ouvert depuis le: 09.18.2021
Site: Paris
Public cible
Adulte
A randomized phase III study of neoadjuvant chemotherapy;followed by surgery versus surgery alone for patients with;High Risk RetroPeritoneal Sarcoma (STRASS 2)
Description de l'essai

This is a multicenter, randomized, open label phase lll trial to assess whether preoperative chemotherapy, as an adjunct to curative-intent surgery, improves the prognosis of high risk DDLPS (dedifferentiated Liposarcoma) and LMS (Leiomyosarcoma) patients as measured by disease free survival.;After confirmation of eligibility criteria, patients will be randomized to either the standard arm or experimental arm.